Health and Wellness
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The proposed system uses brain signals and neural patterns from children.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
The Charge 5 is available today for preorder and will launch with worldwide availability in the fall.
The device predicts cardiac arrests using four primary vital signs.
The platform lets patients with rare diseases access their medical data and participate in research studies.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.
TRIPP PsyAssist will provide protocols and anxiety-easing support to patients undergoing ketamine-assisted therapy.
The app may have been expanded to consumers if it had been successful internally, according to Insider.
The menopause market opportunity has been valued at $600B, and investors are starting to notice innovators.